- FOUNDED 2007
Overview
The Caner Genetics Group provides a national forum for discussion and interaction among clinical, research and support service personnel engaged in cancer genetics research, treatment and management.
Originally established as the Familial Cancer Group within COSA, the Group merged with the Human Genetics Society of Australasia (HGSA) Cancer Genetics Special Interest Group in 2020.
The Group is represented by an Executive Committee with interest in the germline and somatic aspects of cancer genetics.
Membership includes a broad range of professionals, including: Clinical Geneticists, Genetic Counsellors, Oncologists, Scientists, Researchers and others who have an interest in cancer genetics across Australasia.
Some of the issues in which the Group has interest include:
- supporting continuing education of cancer health care professionals on relevant cancer genetics topics
- facilitating networks within familial and/or somatic cancer genetics communities in Australia to accelerate the translation of genetic discoveries into meaningful improvements in care pathways and outcomes for patients
- development of consistent clinical protocols across Australia
- advocacy on issues related to cancer genetics
The Group holds professional development days and webinars, and contributes to various scientific meetings.
Group information
COSA and HGSA Cancer Genetics Group Terms of Reference – Council approved 16 October 2020
What’s the latest
Group Chair

Group Chair
Simon Troth
Cancer Genetics Group Chair & HGSA Representative
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology 9 hours ago
RT by @COSAoncology: We can't thank enough all those who helped our team locally: @HNEHealth @UON_research Calvary Mater Newcastle, all our…
Read More >
COSAoncology 10 hours ago
RT by @COSAoncology: Data from recent #cancersurvivorship symposium. We need tools (https://t.co/9CokjAtani) to extend basic psychological c…
Read More >
COSAoncology 3 days ago
RT by @COSAoncology: 🚨1 week left🚨 to submit your expressions of interest to join the @COSAoncology Survivorship Executive Committee. EOI’s…
Read More >
COSAoncology 4 days ago
RT by @COSAoncology: Dr Robyn Brennen’s Clinical Oncology Society of Australia (COSA) poster #2: Adjuvant therapy was associated with increase…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Such an important area of research and applies all over the world. Huge disparities for Australia's First Peoples as wel…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Great opportunity to make a difference in the lives of people with Head & Neck Cancer. #HNCSM #PHD @hncanceraus @Sydney_Uni @Us…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: .@Sabesan68 @profevasegelov @jrzalcberg @COSAoncology @VCCCAlliance @RtnVic @awrccentre @MOGA_ORG #dct
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Hybrid #decentralized #clinicaltrials and #telehealth to improve patient access to trials are coming 💊 Site, sponsor and r…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Our @COSAoncology Survivorship Executive Committee is seeking expressions of interest for new members. If you’re a COSA…
Read More >